For research use only. Not for therapeutic Use.
Dalbavancin-d6(Cat No.:R034662) is a deuterated version of Dalbavancin, where six hydrogen atoms are replaced with deuterium. This isotopic labeling enhances the stability and improves the analytical detectability of the molecule, making it extremely useful for pharmacokinetic and metabolic studies. Dalbavancin is a long-acting, lipoglycopeptide antibiotic used primarily to treat skin infections caused by Gram-positive bacteria, including MRSA (methicillin-resistant Staphylococcus aureus). The deuterated version, Dalbavancin-d6, provides more accurate data on the drug’s behavior in the body, facilitating the development of effective dosing strategies and contributing to better clinical outcomes in bacterial infection treatments.
Catalog Number | R034662 |
CAS Number | 1126461-54-8 |
Synonyms | A-A 1-d6; BI 397-d6; Dalbavancin B0-d6; MDL 63397-d6; VER 001-d6; 5,31-Dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-[2-deoxy-2-[(10-methyl-1-oxoundecyl)amino]-β-D-glucopyranuronosyl]-38-[[[3-(dimethylamino)prop |
Molecular Formula | C₈₈H₉₄D₆Cl₂N₁₀O₂₈ |
Purity | ≥95% |
Storage | -20°C |